Explore the complexities of non-clear cell renal cell carcinoma, its treatment challenges, and promising immunotherapy advancements for better patient outcomes.

Abstract 585 Background: Collecting duct carcinoma (CDC) originates from the principal cells of the collecting ducts in the renal medulla and accounts for less than 2% of all renal cell carcinomas ...

The paper explained Problem Collecting duct carcinoma (CDC) remains a lethal and aggressive form of kidney cancer with no effective treatment, primarily because of our limited understanding of its ...

To determine whether stimulation of collecting duct renin is a blood pressure–dependent effect; changes in collecting duct renin and associated parameters were assessed in both kidneys of 2-kidney, ...

I also focused on my presentation on the smaller but very important datasets around the very rare histologies like chromophobe kidney cancer, collecting duct kidney cancer and renal medullary cancer.

Collecting duct (Bellini duct) carcinoma (CDC) is a histological variant of renal malignancy originating in the duct of Bellini of the kidney. CDC has been described by numerous synonyms like Bellini ...

Collecting duct carcinoma is a rare and aggressive form of kidney cancer. Learn more about its causes and symptoms here.

The structure and function of the kidney, including its roles in urine production and homeostasis. This is the first in a series of articles examining the renal system.

At this moment, the designation of Bellini tract tumors was carried out because the origins of these tumors appeared to arise from the collecting duct epithelium. By 1997, the Heidelberg ...

Researchers discussed the symptoms, diagnosis, therapy, and prognosis of collecting duct carcinoma (CDC) of the kidney in a study.

Objective: Renal collecting duct carcinoma (CDC) is an extremely rare disease with few studies, and the current understanding of its prognosis is limited. We used the Surveillance, Epidemiology, and ...